Fate Therapeutics's total assets for Q4 2025 were $318.94M, a decrease of -7.20% from the previous quarter. FATE total liabilities were $111.75M for the fiscal quarter, a 1.96% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.